2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01825551 (ClinicalTrials.gov)	November 2012	13/3/2013	The Effect of GCSF in the Treatment of ALS Patients	The Effect of Granulocyte Colony Stimulating Factor (GCSF) in the Treatment of Amyotrophic Lateral Sclerosis (ALS) Patients Referred to Tehran Imam Khomeini and Shariati Hospital Centers in 2013	Amyotrophic Lateral Sclerosis	Drug: Granulocyte Colony Stimulating Factor;Drug: Placebo	Tehran University of Medical Sciences	NULL	Completed	18 Years	85 Years	Both	40	Phase 2/Phase 3	Iran, Islamic Republic of
2	NCT00397423 (ClinicalTrials.gov)	December 2006	8/11/2006	G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response	Granulocyte-Colony Stimulating Factor Treatment for Amyotrophic Lateral Sclerosis: A Randomized Control Trial Study Assessing Clinical Response	Amyotrophic Lateral Sclerosis	Drug: Granulocyte Colony Stimulating Factor;Drug: NS	Peking University	NULL	Completed	18 Years	65 Years	Both	40	Phase 2	China